Part 4: Myelodysplastic syndromes— reatment of low-risk patients with the 5q deletion
Hematol., Transfus. Cell Ther. (Impr.)
;
40(3): 274-277, July-Sept. 2018.
Article
in English
| LILACS
| ID: biblio-953839
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Thalidomide
/
Myelodysplastic Syndromes
/
Erythropoietin
/
Gene Deletion
/
Lenalidomide
Type of study:
Etiology study
/
Practice guideline
/
Risk factors
Limits:
Humans
Language:
English
Journal:
Hematol., Transfus. Cell Ther. (Impr.)
Journal subject:
Hematologia
/
TransfusÆo de Sangue
Year:
2018
Type:
Article
Affiliation country:
Brazil
Institution/Affiliation country:
Associação Médica Brasileira/BR
/
Universidade Federal do Ceará - UFC/BR
/
Universidade de São Paulo - USP/BR
Similar
MEDLINE
...
LILACS
LIS